Multimeric Biotherapeutics, Inc.

Multimeric Biotherapeutics makes medicines that unleash the power of the immune system to treat cancer and serious infections.

  • Stage $500K in TTM Revenue
  • Industry Biotechnology
  • Location San Diego, CA, USA
  • Currency USD
  • Founded February 2008
  • Employees 3
  • Website multimericbio.com

Company Summary

"Multimeric" is a clinical-stage company that makes products to strengthen the immune system. The lead product, MegaCD40L™, is based on CD40 ligand (CD40L), the most powerful immune stimulator made by the body. MegaCD40L™ also kills ovarian cancer cells but is harmless to normal cells, opening up the potential for billion dollar sales as a treatment for ovarian cancer. Follow-on products will make much needed vaccines for infectious diseases.

Team

  • David A Roth
    Chief Operating Officer

    UC Berkeley-trained Ph.D. scientist with vast experience in drug development for public and private companies.

  • Richard S Kornbluth
    President & Chief Scientific Officer

    Harvard-trained M.D., Ph.D. physician-scientist, inventor of the company's technology, chief point of contact

  • Richard Kornbluth

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free